Geoffrey Block, MD

Trials

Studies that name Geoffrey Block, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:02 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT05951192 · A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

  USRC Kidney Research · completed · Anemia, Renal Insufficiency, Chronic, Renal Anemia · principal investigator
• Ph3
  NCT02268994 · KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD

  Keryx Biopharmaceuticals · completed · Anemia of Chronic Kidney Disease · study chair
• Ph2
  NCT01736397 · Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

  Keryx Biopharmaceuticals · completed · Iron Deficiency, Iron Deficiency Anemia · study chair
• Ph1
  NCT01717248 · Safety Study of GCS-100 to Treat Chronic Kidney Disease

  La Jolla Pharmaceutical Company · completed · Chronic Kidney Disease · principal investigator
• N/A
  NCT01475760 · A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease

  Denver Nephrologists, P.C. · completed · Chronic Kidney Disease · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.